Hypercalcemia in 25 OH D3 treated patients receiving a calcium exchange resin.

Labeeuw, M

Hypercalcemia in 25 OH D3 treated patients receiving a calcium exchange resin. [electronic resource] - International journal of clinical pharmacology, therapy, and toxicology Jun 1985 - 316-9 p. digital

Publication Type: Case Reports; Journal Article

0174-4879


Calcifediol--adverse effects
Calcium--blood
Diabetic Nephropathies--therapy
Female
Humans
Hypercalcemia--blood
Ion Exchange Resins--adverse effects
Kidney Failure, Chronic--therapy
Kinetics
Male
Middle Aged
Parathyroid Hormone--blood
Polycystic Kidney Diseases--therapy
Renal Dialysis